Interview for the LifEscozul Protocol™ conducted with Dr. Eduardo Nuñez.
Interview for the LifEscozul™ Protocol conducted with Dr. Eduardo Nuñez, who is part of the LifEscozul™ Medical Group and also a cancer patient (Escozul™, blue scorpion venom, blue scorpion).
Interview conducted by the Bachelor of Biology. Ariel Portal, on the evolution of Dr Eduardo Nuñez ,who presents a lung cancer, within the LifEscozul™ Protocol (Escozul™, poison of the blue scorpion, poison of the blue scorpion).
Dr. Eduardo Nuñez entered the LifEscozul Protocol™ in 2013 diagnosed with lung cancer without the possibility of surgery or chemotherapy. Dr. Eduardo was treated under the LifEscozul™ protocol (protein active ingredient) with periodic controls and progressive dose increases.
Learn about the evolution of Dr. Eduardo Nuñez, in his own words, within the protocol in the last 5 years.
LifEscozul™ is a product with a registered trademark in the USA and Ecuador and in the process of registration in more than 20 countries. It has been developed by Cuban doctors and scientists based on the antitumor active ingredient extracted from blue scorpion venom (Escozul™).